Please Read Our Disclaimer

Nasal Spray Reduces COVID Severity

Nasal Spray Reduces COVID Severity

A pharmaceutical company in Vancouver, Canada called SaNOtize, has been developing topical antimicrobial products to help fight drug resistant infections, and recently, to fight SARS-CoV-2, the cause of COVID-19.

Tags: COVID, COVID-19, early treatment, Nasal spray, prevention, prophylaxis

Share:

Related Posts

Florida’s Surgeon General challenges the FDA and CDC.

The balance of risks and benefits in the COVID-19 “vaccine hesitancy” literature: An umbrella review

Left unchecked, the arbitrary power of the College of Physicians and Surgeons of BC threatens the health and well-being of all British Columbians as well as the core values of Canadian democracy

Search

Top Categories

WANT TO BECOME A MEMBER?

To learn more about how you can join the Canadian Covid Care Alliance click the link below.

Popular Posts

Real Time Ethics – About Misinformation, Disinformation, and Scientific Discourse

The Endemic Hypothesis: Infectious Clones and Virus Isolation

You’ve been “Nudged”!

The Building Case Against COVID-19 Vaccination of Students in Canada

Letter to Members of the BC Legislative Assembly Requesting the Repeal of the Health Professions and Occupations Act

Stay Connected

Canadian Covid Care Alliance